Radiolabeled native low-density lipoprotein injected into patients with carotid stenosis accumulates in macrophages of atherosclerotic plaque: Effect of vitamin E supplementation

Circulation

Volumn 101, Issue 11, 2000, Pages 1249-1254

  Iuliano, L ^a   Mauriello, A ^b   Sbarigia, E ^a   Spagnoli, L G ^b   Violi, Francesco ^a,c  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c POLICLINICO UMBERTO I   (Italy)

Author keywords

Atherosclerosis; Lipoproteins; Oxidant stress; Plaque; Stenosis

Indexed keywords

ALPHA ACTIN; ALPHA TOCOPHEROL; LOW DENSITY LIPOPROTEIN; SERUM ALBUMIN;

AGED; ARTERY WALL; ARTICLE; ATHEROSCLEROSIS; AUTORADIOGRAPHY; CAROTID ARTERY OBSTRUCTION; CLINICAL ARTICLE; CONTROLLED STUDY; ENDARTERECTOMY; FEMALE; FOAM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; PRIORITY JOURNAL; STROKE; TRANSIENT ISCHEMIC ATTACK; VITAMIN SUPPLEMENTATION;

EID: 0034696612     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.11.1249     Document Type: Article

References (24)

1. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modification of low-density lipoprotein that increases its atherogenicity. N Engl J Med. 1989;320:915-924.
2. Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet. 1994;334:793-795.
3. Daugherty A, Zwiefel BS, Sobel BE, Schonfeld G. Isolation and characterization of low density lipoproteins from atherosclerotic vascular tissue of Watanabe heritable hyperlipidemic rabbits. Arteriosclerosis. 1988;8:768-777.
4. Yla-Herttuala S, Palinski W, Rosenfeld ME, Parthasarathy S, Carew TE, Butler S, Witztum JL, Steinberg D. Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J Clin Invest. 1989;84:1086-1095.
5. Haberland ME, Fong D, Chen L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science. 1988;241:215-218.
6. Salonen JT, Yla-Herttuala S, Yamamoto R, Butler S, Korpela R, Salonen K, Nyyssonen K, Palinski W, Witztum JL. Autoantibody against oxidized LDL and progression of carotid atherosclerosis. Lancet. 1992;339:883-887.
7. Chung BH, Segrest JP, Ray JR, Brunzell JD, Hokanson JE, Krauss RM, Beaudrie K, Cone JT. Single vertical spin gradient ultracentrifugation. Methods Enzymol. 1986;128:181-209.
8. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klent DJ. Measurement of protein using bicinchoninic acid. Anal Biochem. 1985;150:76-85.
9. Bilheimer DW, Eisenberg S, Levy RI. The metabolism of very low density lipoprotein proteins, I: preliminary in vitro and in vivo observations. Biochem Biophys Acta. 1972;260:212-221.
10. Iuliano L, Colavita AR, Camastra C, Bello V, Quintarelli C, Alessandroni M, Piovella F, Violi F. Protection of low density lipoprotein oxidation at chemical and cellular level by the antioxidant drug dipyridamole. Br J Pharmacol. 1996;119:1438-1446.
11. 2α by human monocytes: discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem. 1996;271:8919-8924.
12. 2-isoprostanes in human atherosclerotic lesions. J Clin Invest. 1997;100:2028-2034.
13. Pulford KAF, Rigney EM, Miclem KJ, Jones M, Stross WP, Gatter KC, Mason DY. KP1: a new monoclonal antibody that detects a monocyte/macrophage associated antigen in routinely processed tissue sections. J Clin Pathol. 1989;42:14-21.
14. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillesen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103: 2787-2796.
15. Praticò D, Iuliano L, Basili S, Ferro D, Camastra C, Cordova C, FitzGerald GA, Violi F. Enhanced lipid peroxidation in hepatic cirrhosis. J Invest Med. 1998;46:51-57.
16. Stary HC, Chandler AB, Dinsmore RE, Fuster V, Glagov S, Insull W, Rosenfeld ME, Schwartz CJ, Wagner WD, Wissler RW. A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis: a report from the Committee on Vascular Lesions of the Council on Atherosclerosis, American Heart Association. Circulation. 1995;92:1355-1374.
17. Brown MS, Goldestein JL. Lipoprotein metabolism in the macrophage: implication for cholesterol deposition in atherosclerosis. Ann Rev Biochem. 1983;12:223-261.
18. 99mTc-labeled low density lipoproteins. Arteriosclerosis. 1988;8:461-470.
19. 99technetium labeled oxidized LDL in man. Atherosclerosis. 1996;126:131-141.
20. Napoli C, D'Armiento FP, Mancini FP, Postiglione A, Witztum JL, Palumbo G, Palinski W. Fatty streak formation occurs in human fetal aortas and is greatly enhanced by maternal hypercholesterolemia. J Clin Invest. 1997;100:2680-2690.
21. Gotto AM. Cholesterol management in theory and practice. Circulation. 1997;96:4424-4430.
22. Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 1988;85: 9748-9752.
23. Calara F, Dimayuga P, Niemann A, Thyberg J, Diczfalusy U, Witztum JL, Palinski W, Shah K, Cercek B, Nilsson J, Regnström J. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arterioscler Thromb Vasc Biol. 1998;18:884-893.
24. Praticò D, Tangirala RK, Rader D, Rokach J, FitzGerald GA. Vitamin e suppresses isoprostane generation in vivo and reduces atherosclerosis in Apo E-deficient mice. Nat Med. 1998;4:1189-1192.